Genexine, Inc. (KOSDAQ:095700)
1,776.00
-100.00 (-5.33%)
Nov 20, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 80.77 billion as of November 20, 2026. It is the 28,172nd most valuable company in the world and the 1,326th biggest in South Korea. Its market cap has decreased by 63.00% in one year.
Market Cap
80.77B
Enterprise Value
n/a
Revenue
5.81B
Global Rank
Country Rank
#1,326 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 15, 2009, Genexine's market cap has decreased from 109.02B to 80.77B, a decrease of -25.91%. That is a compound annual growth rate of -1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 80.77B | -62.09% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 148.32B |
| Helixmith | 146.20B |
| NeoImmuneTech | 139.40B |
| Anterogen.Co.,Ltd. | 129.88B |
| MedPacto | 125.28B |
| HLB Therapeutics | 102.77B |
| Vaxcell-Bio Therapeutics | 81.75B |
| iNtRON Biotechnology | 76.77B |